Provenienza dei contatti di primo grado di Michael A. Darwin
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 19 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Michael A. Darwin tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Private Equity Investor Chief Tech/Sci/R&D Officer | |
BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Private Equity Investor Sales & Marketing | |
NOVAVAX, INC. | Biotechnology | Chief Executive Officer | |
Rochester Christian University | College/University | Undergraduate Degree | |
MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Baker Bros. Advisors LP
Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Investment Managers | Portfolio Manager-Equities | |
MAXCYTE, INC. | Biotechnology | Director/Board Member | |
Stanford University | College/University | Doctorate Degree | |
Kleiner Perkins Caufield & Byers LLC
Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers LLC (Kleiner Perkins Caufield & Byers) is a venture capital firm founded in 1972 by Eugene Kleiner, Thomas Perkins, Brook Byers and Frank J. Caufield. The firm is headquartered in California, US. | Investment Managers | Consultant / Advisor | |
University of Illinois | College/University | Undergraduate Degree | |
Western Illinois University | College/University | Undergraduate Degree | |
IOMAI CORPORATION | Biotechnology | Chief Executive Officer | |
The New York City Investment Fund Manager, Inc.
The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager Inc. (The New York City Investment Fund Manager) is a venture capital firm founded by Henry Kravis in 1996. The firm is headquartered in New York, United States. | Investment Managers | Consultant / Advisor | |
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Human Resources Officer | |
Biotechnology Association of Alabama
Biotechnology Association of Alabama Miscellaneous Commercial ServicesCommercial Services The Biotechnology Association of Alabama is a leading advocate for the state's bioeconomy. The private company is based in Birmingham, AL. The company represents the state on a national and international stage, promoting the intellectual and innovative capital that make Alabama a premier place to invest, start, and grow in bioscience. The company was founded by Thomas P. Dooley. | Miscellaneous Commercial Services | President Director/Board Member | |
Integrated Genetics, Inc.
Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Part of Laboratory Corp. of America Holdings, Integrated Genetics, Inc. is a pharmaceutical preparations company. The company is based in Framingham, MA. The company was founded by Robert J. Carpenter. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The University of Alabama at Birmingham | College/University | President Graduate Degree | |
The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
ARMO BIOSCIENCES INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
KINIKSA PHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Director/Board Member | |
Vivelix Pharmaceuticals, Ltd.
Vivelix Pharmaceuticals, Ltd. Pharmaceuticals: MajorHealth Technology Vivelix Pharmaceuticals, Ltd. manufactures and sells pharmaceutical products. The private company is based in Hamilton, BM. and has subsidiaries in the United States. The Bermudian company was founded by William P. Forbes. | Pharmaceuticals: Major | Director/Board Member | |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Biotechnology | Chief Executive Officer | |
THESEUS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
TSCAN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
MBX Biosciences, Inc.
MBX Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology MBX Biosciences, Inc. operates as a preclinical-stage biotech company. It creates therapies to treat rare endocrine diseases. The company was founded by Peter Kent Hawryluk and Timothy Knickerbocker and is headquartered in Carmel, IN. | Electronic Equipment/Instruments | Director/Board Member | |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | Pharmaceuticals: Other | Director/Board Member | |
KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
Frontera Therapeutics (HK) Ltd.
Frontera Therapeutics (HK) Ltd. Pharmaceuticals: MajorHealth Technology Part of Frontera Therapeutics, Inc., Frontera Therapeutics (HK) Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company was founded by Yong Dai and Yong Dai has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Odyssey Therapeutics, Inc.
Odyssey Therapeutics, Inc. Packaged SoftwareTechnology Services Odyssey Therapeutics, Inc. is a biotechnology company that specializes in discovering, developing, and commercializing immunomodulators and oncology medicines. The company is based in Medfield, MA and has subsidiaries in the United Kingdom. The company is composed of a team of drug hunters, scientists, and industry leaders in foundational biology, chemistry, and data sciences. Odyssey Therapeutics aims to transform drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients. Odyssey Therapeutics was founded by David L. Pompliano, Gary D. Glick, and Melissa Merrick, with Gary D. Glick serving as the CEO since incorporation. | Packaged Software | Director/Board Member | |
ADICET BIO, INC. | Pharmaceuticals: Major | Chairman | |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Learning Undefeated, Inc.
Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Learning Undefeated, Inc. is a non-profit organization that provides STEM education opportunities for underserved communities. The non-profit company is based in Gaithersburg. The American company's flagship education program features mobile STEM labs that have provided hands-on learning opportunities to more than 200,000 K-12 students in 18 states since 2003. The company also operates several other celebrated STEM education programs including the Young Science Explorers program, a summer camp for middle school students, and the Advancing Tomorrow's Leaders in STEM (ATLAS) college and career exploration program. Learning Undefeated is driving race and gender equity in STEM through experiential and deep-impact learning experiences for students from under-resourced communities. | Investment Trusts/Mutual Funds | Director/Board Member | |
ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Xinthera, Inc.
Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., XinThera, Inc. is a drug discovery company focused on building a small molecule oncology and immunology pipeline. The company is based in San Diego, CA. XinThera is backed by a group of international investors including Foresite Capital, OrbiMed Advisors, LLC, and TTM Capital. XinThera's lead programs focus on well-validated targets with a mission to rapidly create and advance fast-follower programs with potential in areas of high-unmet need. XinThera was founded by Qing Dong, Stephen W. Kaldor, and Gene Hung. The CEO is Christopher C. LeMasters. | Pharmaceuticals: Major | Director/Board Member | |
Gwynant Therapeutics
Gwynant Therapeutics Pharmaceuticals: MajorHealth Technology Gwynant Therapeutics develops new small molecules for oncology targets. | Pharmaceuticals: Major | Director/Board Member | |
Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc. BiotechnologyHealth Technology Garuda Therapeutics, Inc. aims to eliminate the need for donor or patient cells for blood stem cell transplants. The company is based in Natick, MA. The company's platform technology generates off-the-shelf, self-renewing blood stem cells that are HLA-compatible and transgene-free. This technology could potentially provide curative therapies for over 120 diseases. Garuda Therapeutics was founded by Dhvanit Shah, Sean Morrison, and David T. Scadden, with Dhvanit Shah serving as CEO since incorporation. | Biotechnology | Director/Board Member | |
Electra Therapeutics, Inc.
Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Electra Therapeutics, Inc. is a clinical stage biotechnology company that develops therapies for the treatment of immunological diseases and cancer. The company is based in San Francisco, CA. The company's lead product candidate, ela026, is a monoclonal antibody that targets sirp on the cell surface of and t cells, and precisely depletes pathological immune cells. Electra currently has one program in clinical development and additional preclinical programs. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Star Therapeutics, Inc. is an American company that aims to develop life-changing therapies for rare diseases. The company's mission is to help millions of patients in urgent need. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | Biotechnology | Director/Board Member Director/Board Member | |
Burns McClellan, Inc.
Burns McClellan, Inc. Miscellaneous Commercial ServicesCommercial Services Burns McClellan, Inc. provides public and investor relations services. The private company is based in New York, NY. | Miscellaneous Commercial Services | Public Communications Contact | |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
X4 Pharmaceuticals (Austria) GmbH | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 45 |
Germania | 2 |
Bermuda | 2 |
Canada | 2 |
Hong Kong | 2 |
Settori
Health Technology | 34 |
Consumer Services | 7 |
Finance | 4 |
Electronic Technology | 3 |
Commercial Services | 3 |
Posizioni
Director/Board Member | 108 |
Corporate Officer/Principal | 41 |
Independent Dir/Board Member | 34 |
Undergraduate Degree | 15 |
Chairman | 11 |
Contatti più connessi
- Borsa valori
- Insiders
- Michael A. Darwin
- Connessioni Società